MITODAC

Pharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; compounds for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes; pharmaceutical drugs; pharmaceutical compositions; pharmaceuticals; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations for the treatment of degenerative brain disease